HSPA5 and cancer: In oncology, GRP78 is consistently overexpressed in tumors, where it contributes to cancer cell survival, resistance to chemotherapy, and poor prognosis, thus being pursued as a therapeutic target with antibodies, peptides, and small molecules [11].